Opportunity overview
Provision of the Oncotype DX Breast Recurrence Score test.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Exact Sciences UK, Ltd.
Matched by exact name
- Contract value
- £326.7k
- Awarded
- Not supplied
- Contract signed
- 6 Mar 2026
- Award ID
- 025052-2026-1
- Status
- active
- Identifier
- 07484560
- Location
- London, UKI45, SE1 7LY, United Kingdom
Classification
- CPV85111800 — Pathology services
Lots
- Oncotype DX genomic testing for breast cancer.<br/><br/>This notice is confirmation of an award having been made based on a framework agreement and without competition.<br/><br/>The lifetime value of the contract is expected to be £326,700.00 call off order.<br/><br/>The contract dates are 14 March 2026 to 13 March 2027. <br/><br/>This is an existing service with an existing provider.Value not stated